Skip to main content
$1.71 -$0.02 (-1.2%)

04:00 PM EDT on 04/14/21

Trevena, Inc. (NASDAQ:TRVN)

CAPS Rating: 3 out of 5

Current Price $1.71 Mkt Cap $279.0M
Open $1.71 P/E Ratio 0.00
Prev. Close $1.71 Div. (Yield) $0.00 (0.0%)
Daily Range $1.69 - $1.77 Volume 1,241,913
52-Wk Range $0.61 - $3.68 Avg. Daily Vol. 2,826,297

Caps

How do you think NASDAQ:TRVN will perform against the market?

Add Stock to CAPS Watchlist

All Players

50 Outperform
2 Underperform
 

All-Star Players

9 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:TRVN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

tomfoolme (67.13)
Submitted February 10, 2021

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. 453M pe- div-. Pain killer in stage 3. Rev is just starting. All-stars 12/0

TSIF (99.99)
Submitted September 01, 2015

Trevena has some solid followers, but the froth after the Phase 2 data is excessive at this point. Cash burn high, investment "raise" needed before Phase III gets much traction. Well respected Barron's suggests target $20, so this one may get a bit… More

NASDAQ:TRVN VS S&P 500 (SPY)

NASDAQ:TRVN Summary

Fools bullish on NASDAQ:TRVN are also bullish on:

Fools bearish on NASDAQ:TRVN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about TRVN.

Recs

1
Member Avatar tomfoolme (67.13) Submitted: 2/10/2021 3:05:03 AM : Outperform Start Price: $2.92 NASDAQ:TRVN Score: -46.37

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. 453M pe- div-. Pain killer in stage 3. Rev is just starting. All-stars 12/0

Recs

0
Member Avatar chellur (< 20) Submitted: 9/29/2020 8:37:32 PM : Outperform Start Price: $2.90 NASDAQ:TRVN Score: -64.54

TRVN'S treatment has been given the go ahead for the management of acute pain in adults who require an intravenous opioid pain reliever. This will propel the stock much higher in the long term.

Recs

0
Member Avatar TMFZhiyuanSun (40.20) Submitted: 9/18/2020 1:15:29 AM : Outperform Start Price: $2.17 NASDAQ:TRVN Score: -32.91

Commercialization of a favorable opioid drug.

Leaderboard

Find the members with the highest scoring picks in TRVN.

Score Leader

MichaelDFS

MichaelDFS (97.99) Score: +123.44

The Score Leader is the player with the highest score across all their picks in TRVN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
MichaelDFS 97.99 3/17/2020 Outperform 1Y $0.60 +186.67% +63.23% +123.44 0 Comment
NorteClub 29.48 7/29/2020 Underperform 5Y $2.21 -22.62% +27.73% +50.36 0 Comment
superstar 99.93 10/10/2018 Outperform 5Y $0.91 +88.33% +44.99% +43.34 1 Comment
AtlanticoClub < 20 7/24/2020 Underperform 5Y $1.95 -12.31% +28.40% +40.71 0 Comment
Paco57 67.13 5/13/2020 6/19/2020 Outperform 1Y $1.19 +43.70% +43.82% -0.12 0 Comment
DharmaBum < 20 3/31/2021 Outperform 3M $1.81 -5.52% +4.07% -9.60 0 Comment
rlevine99 < 20 5/29/2020 Outperform 5Y $1.40 +22.14% +36.26% -14.11 1 Comment
PayrollGeek 40.07 5/29/2020 Outperform 3Y $1.40 +22.14% +36.26% -14.11 0 Comment
WeRStellar < 20 3/5/2021 Outperform 5Y $1.81 -5.47% +9.98% -15.45 0 Comment
TMFZhiyuanSun 40.20 12/8/2020 Outperform 5Y $2.17 -21.20% +11.71% -32.91 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for TRVN.